Biography of Byron Robinson
Last update: February 20, 2024Career
Byron was Global Head of Clinical Development Strategy and Innovation at EMD Serono, and Vice President, Senior Global Program and Head, Oncology at Bayer. Byron Robinson joined Janux Therapeutics in 2022.
Byron Robinson is currently Chief Strategy Officer at Janux Therapeutics - View - Janux Therapeutics org chart
Create your alert
to follow the career of Byron Robinson.
Education
Byron Robinson has a PhD in Organic Chemistry from University Of New England, Maine in 1991 and a Juris Doctor from Santa Barbara College of Law in 2008.
They have also studied at University Of New England, Maine :
- Liz Ranieri - Telstra Corporation
- Claire McCaffery - Accenture ANZ
- Nicholas Scofield - Allianz Australia
Find more alumni from University Of New England, Maine
More about Byron Robinson
Selected links
Do you need to know more about Byron Robinson? More results.
Participate
Social media
- Byron Robinson on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Byron Robinson
The colleagues of Byron Robinson
Company Colleagues
- At Janux Therapeutics, Byron Robinson has 17 colleagues including David Campbell (CEO & Director), Winston Kung (Director)…
Industry Colleagues
- In the Biotechnology industry, Byron Robinson has 30,251 colleagues in 2,282 companies located in 40 countries. 14,430 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Byron Robinson.
